Karyopharm Therapeutics Inc (KPTI) — Cash Flow Quality Index

Latest as of June 2024: -1.62x

Karyopharm Therapeutics Inc (KPTI) has a Cash Flow Quality Index of -1.62x as of June 2024. Operating cash flow of $-38.50 Million is below net income of $23.79 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Karyopharm Therapeutics Inc generate cash to assess how effectively this company generates cash.

Cash Flow Quality Index

-1.62x

Operating CF / Net Income

Operating Cash Flow

$-38.50 Million

USD

Net Income

$23.79 Million

USD

Data as of

Jun 2024

Most recent filing

Annual Cash Flow Quality Index for Karyopharm Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Karyopharm Therapeutics Inc. For live market cap and the full company financial profile, see Karyopharm Therapeutics Inc stock valuation.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.